On the stock market since 2008, it operates in the world of health and science. It has 104 employees. Now — the numbers.
This is an established company with proven profits.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
If every debt were paid off today, $62.0M would still be left in the vault — a solid cushion for hard times.
Executives buying with their own money is usually read as confidence in the company’s future.
The stock trades 58% below its peak. The market has trimmed its expectations for the company.
There is $64.8M in the vault; even if every debt were paid off, $62.0M would remain.
It met or beat analyst expectations in 7 of the last 7 quarters — consistency is a promise kept.
Over the last 12 months, company executives reported 11 buys and 7 sells. Management buying with its own money is usually read as a good sign.
This stock swings about 2.2 times as much as the market average. Big rallies — and big drops — can both happen fast.
Since the drop from its peak, buyer appetite hasn’t come back.
On our five-subject report card, CDXC sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: CDXC is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.